RetaMaps

Solace Med Spa

Solace Med Spa · 7520 FM 3180 Road · Baytown, TX 77523

4.8· 114 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

About this practice

Solace Med Spa is a medical spa in Baytown, Texas, owned, per its website, by Shannon Bolinger, PA-C, a board-certified physician associate with over 10 years in aesthetics. The site lists injectables, skin and laser care, weight loss, hormone therapy, a sauna and a cold plunge, and describes a personalized plan built around each client's goals. Google shows a 4.8-star rating across 114 reviews dating back to 2021, 49 in the past year, with reviewers most often mentioning the staff (30 reviews) and the providers' knowledge (29).

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.8
Google rating · 114 reviews
49
reviews in the past year (avg ★ 5.0)
2
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-24. Read the reviews themselves on the practice's Google listing.

What patients say

This practice holds a ★4.8 Google rating across 114 reviews. 94% of the 100 reviews we analyzed are 5-star. reviewers most often mention staff & front desk (30), professionalism & expertise (29), results (9), feeling listened to (5).

5★
94
4★
1
3★
0
2★
1
1★
4

Most recent Google reviews

Lasse★★★★★2026-09-18

My absolute favorite place to go and get pampered and refreshed. The providers and staff at Solace are knowledgeable, friendly, and always operating on the “next level” in hormone replacement and skin care. ~Lori Cates

Jennifer P.★★★★★2026-09-18

This front desk team is so amazing. Absolutely took the best care of me and were so helpful. Rockstars!!! Shannon goes above and beyond to make you comfortable and beautiful!! Just do it!

Lindsey★★★★★2026-09-16

Love Shannon I trust her completely!!! Rosie is always so helpful when I call.

Anita C.★★★★★2026-09-10

I feel blessed to be at Solace Med Spa! Their knowledge & professionalism is the best. Rosie welcomed me back. Adrian was absolutely the best. I’ve never had a consultation as good as hers. Fantastic to be exact! I was upset about someone I had been seeing not even showing up for my appointment. The more I think about it, the more blessed I feel. All things happen for a reason. And the same person I was upset with told me untruths. So again all things do happen for a reason. Thank you all for welcoming me back. ❤️❤️❤️❤️❤️

Carolyn C.★★★★★2026-09-03

Great environment. Great people. Will recommend over again! A++

Reviews and counts are from this practice's public Google Business listing and reflect their authors' opinions, not RetaMaps'. See all reviews on Google.

Nearby providers in Baytown

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs